150 related articles for article (PubMed ID: 2441151)
1. Cardiovascular actions of a new dihydropyridine calcium antagonist, 8363-S: comparison with nifedipine and nicardipine in awake, unsedated dogs.
Wynsen JC; Shimshak TM; Preuss KC; Hardman HF; Warltier DC
J Cardiovasc Pharmacol; 1987 Jul; 10(1):30-7. PubMed ID: 2441151
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
Nishikibe M; Nagura J; Kamei K; Fukuroda T
Arch Int Pharmacodyn Ther; 1988; 291():7-20. PubMed ID: 3365068
[TBL] [Abstract][Full Text] [Related]
4. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.
Sakanashi M; Noguchi K; Miyamoto Y; Kato T; Nagamine F; Yu WY; Higuchi M; Nakasone J
Arch Int Pharmacodyn Ther; 1988; 294():159-74. PubMed ID: 2976588
[TBL] [Abstract][Full Text] [Related]
6. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
7. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine.
Motomura S; Hashimoto K
Jpn J Pharmacol; 1990 Feb; 52(2):319-30. PubMed ID: 2313939
[TBL] [Abstract][Full Text] [Related]
8. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of the systemic hemodynamics and myocardial oxygen consumption of FRC 8653, a new Ca++ channel blocker, and nifedipine in anesthetized dogs.
Chibana T; Noguchi K; Ojiri Y; Sakanashi M
Jpn Heart J; 1992 Mar; 33(2):239-52. PubMed ID: 1593752
[TBL] [Abstract][Full Text] [Related]
10. Influences of the calcium antagonists nicardipine and nifedipine, and the calcium agonist BAY-K-8644, on the pharmacokinetics of propranolol in rats.
Vercruysse I; Schoors DF; Massart DL; Dupont AG
Cardiovasc Drugs Ther; 1993 Aug; 7(4):721-6. PubMed ID: 7694636
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of the nifedipine analog, CGP 28 392, in the conscious dog.
Preuss KC; Cheung NL; Brooks HL; Warltier DC
J Cardiovasc Pharmacol; 1984; 6(5):949-53. PubMed ID: 6209505
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
Kanda A; Haruno A; Miyake H; Nagasaka M
J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator and hypotensive effects of the optical isomers of nicardipine (YC-93), a new Ca2+-antagonist.
Takenaka T; Miyazaki I; Asano M; Higuchi S; Maeno H
Jpn J Pharmacol; 1982 Aug; 32(4):665-70. PubMed ID: 7131951
[TBL] [Abstract][Full Text] [Related]
14. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology, pharmacokinetics, and hemodynamic effects of nicardipine.
Singh BN; Josephson MA
Am Heart J; 1990 Feb; 119(2 Pt 2):427-34. PubMed ID: 1967896
[TBL] [Abstract][Full Text] [Related]
16. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
Pruneau D; Roy F; Brown NL
Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
[TBL] [Abstract][Full Text] [Related]
17. Effect of tiapamil and nifedepine during critical coronary stenosis and in the presence of adrenergic beta-receptor blockade in anesthetized dogs.
Saini RK; Fulmor IE; Antonaccio MJ
J Cardiovasc Pharmacol; 1982; 4(5):770-6. PubMed ID: 6182408
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists.
Ohtsuka M; Ono T; Hiroi J; Esumi K; Kikuchi H; Kumada S
J Cardiovasc Pharmacol; 1983; 5(6):1074-82. PubMed ID: 6196557
[TBL] [Abstract][Full Text] [Related]
19. Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine.
Iliopoulou A; Turner P; Warrington SJ
Br J Clin Pharmacol; 1983 Jan; 15(1):59-65. PubMed ID: 6849746
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitropheny l) octyl ester.
Hojo M; Teramoto N; Hata H; Katayama O; Tatsumi H; Shibata S
Arzneimittelforschung; 1992 May; 42(5):621-8. PubMed ID: 1530674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
